The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF, 228K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Itoh, N.
Right arrow Articles by Matsuzawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itoh, N.
Right arrow Articles by Matsuzawa, Y.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/8/613/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 4, August 18, 1997 613-618

Brief Definitive Reports

Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice

Naoto Itoh*, Akihisa Imagawa{ddagger}, Toshiaki Hanafusa{ddagger}, Masako Waguri{ddagger}, Koji Yamamoto{ddagger}, Hiromi Iwahashi{ddagger}, Makoto Moriwaki{ddagger}, Hiromu Nakajima{ddagger}, Junichiro Miyagawa{ddagger}, Mitsuyoshi Namba{ddagger}, Susumu Makino||, Shigekazu Nagata§, Norio Kono*, and Yuji Matsuzawa{ddagger}

From the * Department of Clinical Laboratory Science, School of Allied Health Sciences, {ddagger} Second Department of Internal Medicine, and § Department of Genetics, Faculty of Medicine, Osaka University, Suita, Osaka 565, Japan; and || Center for Experimental Animals Development, Shionogi & Co., Ltd., Koka, Shiga 520-34, Japan


   Abstract
Top
 Abstract
Materials and Methods
 Results
 Discussion
 References
 
Insulin-dependent diabetes mellitus (IDDM) is assumed to be a T cell–mediated autoimmune disease. To investigate the role of Fas-mediated cytotoxicity in pancreatic β cell destruction, we established nonobese diabetic (NOD)-lymphoproliferation (lpr)/lpr mice lacking Fas. Out of three genotypes, female NOD-+/+ and NOD-+/lpr developed spontaneous diabetes by the age of 10 mo with the incidence of 68 and 62%, respectively. In contrast, NOD-lpr/lpr did not develop diabetes or insulitis. To further explore the role of Fas, adoptive transfer experiments were performed. When splenocytes were transferred from diabetic NOD, male NOD-+/+ and NOD-+/lpr developed diabetes with the incidence of 89 and 83%, respectively, whereas NOD-lpr/lpr did not show glycosuria by 12 wk after transfer. Severe mononuclear cell infiltration was revealed in islets of NOD-+/+ and NOD-+/lpr, whereas islet morphology remained intact in NOD-lpr/lpr. These results suggest that Fas-mediated cytotoxicity is required to initiate β cell autoimmunity in NOD mice. Fas–Fas ligand system might be critical for autoimmune β cell destruction leading to IDDM.

Address correspondence to Naoto Itoh, Department of Clinical Laboratory Science, School of Allied Health Sciences, Faculty of Medicine, Osaka University, 1-7 Yamadaoka, Suita, Osaka 565, Japan. Phone: 81-6-879-2584; FAX: 81-6-879-2499; E-mail: nitoh{at}sahs.med.osaka-u.ac.jp

Accumulating evidence has elucidated that insulin-dependent diabetes mellitus (IDDM) is a T cell–mediated autoimmune disease (1, 2). Histological examination of the IDDM pancreas revealed that mononuclear cells infiltrated into the islet (insulitis) and the infiltrate was mainly composed of T cells (3–5). The nonobese diabetic (NOD) mouse is an excellent animal model of human IDDM, and possesses a similar T cell predominance in the islet infiltrate (6). The significant role of T cells in IDDM has been extensively studied by using this mouse model. T cell manipulation by an administration of mAb decreased the incidence of diabetes and insulitis (7, 8). Insulitis and diabetes were adoptively transferred into neonatal or irradiated young NOD by splenic T cells, T cell lines, and T cell clones from diabetic NOD (9–12). Possible roles of these cells are to give an initial damage to β cells for launching inflammatory process, and/or to secrete cytokines for recruiting and activating other T cells, and/or to put the final damage to β cells for causing diabetes. Thus, T cells are essentially involved in the pathogenesis of IDDM, yet exact mechanisms of pancreatic β cell destruction remain obscure.

Recent studies have exposed that T cell–mediated cytotoxicity comprised two major pathways, perforin- and Fas-based mechanisms (13–15). Perforin is a protein present in the cytoplasmic granules of CTLs and secreted to form pores on target cell membranes. The presence of perforin in CD8+ T cells in insulitis lesions of NOD mice suggested β cell lysis by a perforin-based mechanism (16). However, one study using transgenic mice expressing glycoprotein of lymphocytic choriomeningitis virus (LCMV) in β cells, transfer of perforin-deficient glycoprotein of LCMV–specific T cells failed to prevent insulitis (17). That study indicates that the perforin-independent pathway is required to initiate autoimmunity against pancreatic β cells.

Fas-dependent cytotoxicity is a possible molecular mechanism for triggering β cell destruction. To address this issue, we established Fas-lacking NOD mice by introducing lymphoproliferation (lpr) mutation from MRL-lpr/lpr. The MRL-lpr/lpr mouse carries an insertion of an early transposable element in intron 2 of the Fas gene leading to premature termination of the transcript and defective Fas expression on cell surface (18). Generated NOD-lpr/lpr did not develop diabetes or insulitis. In addition, splenocyte-transfer did not provoke insulitis or diabetes either. These results suggest that Fas-mediated cytotoxicity is critical to initiate β cell autoimmunity in NOD mice. Fas–Fas ligand (FasL) system might be required in an initial step of autoimmune β cell destruction leading to IDDM.


   Materials and Methods
Top
 Abstract
 Materials and Methods
Results
 Discussion
 References
 
Mice.
NOD/shi/osa mice were originated from the colony at Center for Experimental Animals Development (Shionogi, Koka, Japan) and bred under specific pathogen-free conditions at the Institute of Animal Research (Osaka University Medical School, Osaka, Japan). They were monitored for the development of diabetes with Tes-Tape (Eli Lilly, Indianapolis, IN) weekly. The incidence of spontaneous diabetes in our colony was 77% in females and 40% in males by 32 wk of age. MRL-lpr/lpr mice were purchased from Japan SLC (Hamamatsu, Japan). Experiments were approved by Osaka University Medical School Animal Care and Use Committee and performed according to Osaka University Medical School Guideline for the Care and Use of Laboratory Animals.

Breeding of NOD-lpr/lpr Mice.
MRL-lpr/lpr mice (H-2k; Kk, I-Ak, I-E+, Dk) were outcrossed to NOD mice (H-2g7; Kd, I-Ag7, I-E–, Db), and F1 were backcrossed in NOD background. At the N2 generation, H-2 was typed to select breeders homozygous for H-2g7 since this characteristic MHC haplotype was essential for insulitis and diabetes (19). Cervical lymphnode was biopsied and dispersed cells (106) were stained with the following monoclonal antibodies. SF1-1.1 for Kd and 28-8-6S for Db were purchased from PharMingen (San Diego, CA) and 14-4-4S for I-E from Cedarlane (Hornby, Ontario, Canada). 11-4.1 for Kk, H116-32.R7 for I-Ak, and 10-2.16 for I-Ag7 were provided by Dr. M. Hattori (Harvard Medical School, Boston, MA). FITC-conjugated anti–mouse IgG Fc (Cappel, Durham, NC) was used as a secondary antibody. Flow cytometric analysis was performed on a FACScan® (Becton Dickinson, Mountain View, CA). lpr mutation was also screened at each step of backcrossing. Tail was biopsied and extracted DNA was subjected to PCR with two different pairs of primers constructed according to the published sequence (20). The first pair is composed of NIL-1, 5'-CAG CAG GAA TCC TAT GAG GT-3' and NIL-2, 5'-CTC GCA ACG TGA ACG GTT CG-3', yielding a band of 381 bp for the mutated allele. The second pair is composed of NIL-3, 5'-CCT TCA TAA CTG GTG TCG CA-3', and NIL-4, 5'-GCA GAG ATG CTA AGC AGC AG-3', yielding a band of 346 bp for the mutated allele.

Genotyping and Phenotyping of Fas Allele.
At the N6 generation, heterozygotes for lpr were intercrossed and N6F1 was obtained. Genotype of the Fas allele was determined by PCR with Takara Ex Taq (Takara Shuzo, Otsu, Japan) and one set of primers, NIL-1, and NIL-4 covering an early transposable element. lpr type yielded a band of 5.7 kbp and wild type yielded a band of 265 bp. Phenotype was confirmed by flow cytometry and Northern blot analysis. Thymocytes and splenocytes were dispersed into single cells (106) and stained with Jo2 anti–mouse Fas antibody (PharMingen) followed by FITC-conjugated anti–hamster IgG (PharMingen), or a combination of PE-conjugated anti-CD4 (GK1.5; Becton Dickinson) and FITC-conjugated anti-CD8 (YTS 169.4; Cedarlane), or a combination of PE-conjugated anti-B220 (RA3-6B2; GIBCO BRL, Gaitherburg, MD) and FITC-conjugated anti-CD3 (145-2C11; PharMingen). Dead cells were excluded by 1 µg/ml of propidium-iodine (Sigma Chemical Co., St. Louis, MO) staining. For Northern blotting, total RNA was prepared from tissue using TRIzol (GIBCO BRL) and blotted onto a nylon membrane. EcoRI fragment of mouse cDNA was labeled with 32P and used for hybridization as described (21).

Monitoring Spontaneous Development of Diabetes.
After genotyping, female congenic mice were monitored for the development of diabetes with Tes-Tape weekly. Diabetes was diagnosed when Tes-Tape indicated >2+ and hyperglycemia >300 mg/dl was confirmed by the measurement of blood glucose using Glutest E (Sanwa Kagaku Kenkyusho, Nagoya, Japan).

Adoptive Cell Transfer.
Cell transfer was performed according to the method of Wicker et al. (22) with slight modification. Splenocytes from diabetic NOD were isolated in RPMI 1640 medium supplemented with 10% fetal bovine serum. RBCs were excluded by a lysis with NH4Cl. After washing, numeration, and viability evaluation, splenocytes (5 x 107) were intravenously injected into sublethally irradiated male recipients. The dose of irradiation was 800 rad, and the age of recipients was between 9 and 13 wk when none of NOD males spontaneously developed diabetes. Development of diabetes was monitored three times a week by Tes-Tape after transfer.

Histological Examination.
Pancreas was fixed on a filter paper in neutral-buffered formalin, and paraffin-embedded sections were prepared as maximum plane could be observed. Two nonconsecutive hematoxylin and eosin sections were examined. For transferred mice, sections were scored for insulitis, and the number of islets was counted by one investigator in a blind fashion. Score of insulitis was 0, normal; 1, peri-insulitis; 2, mononuclear cell infiltration in <50% of the area of the islet; 3, mononuclear cell infiltration in 50% or more of the area of the islet.

Analysis of Microsatellite Markers.
To examine the extent of bringing in MRL genes surrounding lpr mutation to the NOD genetic background, genomes of the N6 backcross used for the intercross were assessed with locus-specific microsatellite markers. IDDM susceptibility (Idd) genes with significant evidence of linkage to insulitis and diabetes (23, 24) were assessed similarly. Microsatellite markers were selected from the published data (25) and the database released by the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research (Cambridge, MA), and screened for polymorphisms between NOD and MRL strains. After MapPairsTM (Res. Genetics, Huntsville, AL) were subsequently used in this study: Idd3, D3Mit270; Idd5, D1Mit122, and D1Mit318; Idd10, D3Mit10, and D3Mit140; chromosome 19, D19Mit11, D19Mit34, D19Mit43, D19Mit54, and D19Mit69.

Statistical Analysis.
The Kaplan-Meier method was used for the calculation of diabetes incidence. Insulitis scores and the number of islet were compared using the Kruskal-Wallis test.


   Results
Top
 Abstract
 Materials and Methods
 Results
Discussion
 References
 
Genotyping and Phenotyping.
Genotyping at the Fas locus determined NOD-+/+, NOD-+/lpr, and NOD-lpr/ lpr. They were all maturated, but NOD-lpr/lpr showed marked lymphadenopathy at ~4 mo of age. This is due to impaired transcription of the Fas gene, defective expression of Fas antigen, and consequent accumulation of CD4–CD8– CD3lowB220+ lymphocytes (Fig. 1). Although the phenotype of NOD-lpr/lpr closely resembled a parental strain, MRL-lpr/lpr, NOD-lpr/lpr did not show high mortality as MRL-lpr/lpr making it possible to observe them until 10 mo of age. NOD-+/+ and NOD-+/lpr could hardly be discriminated by the phenotype.


Figure 1
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 Fas mRNA expression in the thymus (A), Fas expression on thymocytes (B), and two-color flow cytometric analysis of cell surface markers on splenocytes (C) of NOD-+/+ and NOD-lpr/lpr.

 
Spontaneous Development of Diabetes.
Female NOD-+/+ and NOD-+/lpr developed spontaneous diabetes after 3 mo of age. The incidence increased with age and reached 68% in NOD-+/+ and 62% in NOD-+/lpr by 10 mo of age (Fig. 2). This time course is comparable with that in NOD mice in our colony. In contrast, none of NOD-lpr/lpr developed diabetes during this observation period.


Figure 2
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 Cumulative incidence of spontaneous diabetes in female NOD-+/+ (n = 19), NOD-+/lpr (n = 18), and NOD-lpr/lpr (n = 17).

 
Diabetes after Adoptive Cell Transfer.
Prevention of spontaneous diabetes might be due to the distorted cell proportion of immune cells since unusual CD4–CD8– T cells accumulated in NOD-lpr/lpr. To avoid this influence, we performed transfer experiments from diabetic NOD to sublethally irradiated young congenic mice. In a total of four experiments, 8 of 9 NOD-+/+ (89%) and 10 of 12 NOD-+/lpr (83%) developed diabetes, whereas 0 of 7 NOD-lpr/lpr (0%) became diabetic during 12 wk of observation period (Fig. 3).


Figure 3
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 3 Cumulative incidence of adoptively transferred diabetes in male NOD-+/+ (n = 9), NOD-+/lpr (n = 12), and NOD-lpr/lpr (n = 7).

 
Histological Examination.
Mild to severe insulitis existed in the pancreas of both genders of NOD-+/+ and NOD-+/lpr, irrespective of the development of diabetes (Fig. 4). In contrast, mononuclear cells were barely found in and around the islet of both genders of NOD-lpr/lpr. The severity of insulitis and the number of islets were evaluated in transferred mice. The average scores of insulitis (mean ± SE) were 2.47 ± 0.15, 2.36 ± 0.19, and 0.02 ± 0.02 in NOD-+/+, NOD-+/lpr, and NOD-lpr/lpr, respectively (P <0.01). The number of islets per section was decreased in NOD-+/+ (9.89 ± 2.78), and NOD-+/lpr (12.3 ± 2.39), compared with that in NOD-lpr/lpr (52.1 ± 10.2) (P <0.01). Most islets of NOD-+/+ and NOD-+/lpr were inflamed and small in size, indicating the decrease in number resulted from destruction of the islet. Conversely, islets of NOD-lpr/lpr remained normal in morphology.


Figure 4
Figure 4
View larger version (335K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 4 Hematoxylin and eosin staining of pancreatic islets of NOD-+/+ (A) and NOD-lpr/lpr (B) transferred with splenocytes from diabetic NOD. Original magnification was 200.

 
Analysis of Microsatellite Markers.
Genetic regions encompassing lpr mutation were assessed in three pairs of the N6 littermates used for producing the intercross. Although the position of recombination between NOD and MRL strains varied among the pairs (Table 1), either the incidence of diabetes in NOD-+/+ and NOD-+/lpr or the protection of insulitis and diabetes in NOD-lpr/lpr did not change among the F1 intercross of these pairs. Markers linked to Idd3, Idd5, and Idd10 loci were all homozygous for NOD alleles.


View this table:
[in this window]
[in a new window]

  		Table 1 Analysis of Microsatellite Markers of the N6 NOD-+/lpr Mice Used for the Intercross

 

   Discussion
Top
 Abstract
 Materials and Methods
 Results
 Discussion
References
 
The dominant role of T cells in the pathogenesis of IDDM has been strongly suggested by many investigators, but exact molecular mechanisms have remained elusive. Recent advances in the understanding of T cell–mediated cytotoxicity disclosed the possibility that β cells were destroyed by perforin- or Fas-based mechanisms. In fact, perforin-deficient LCMV-transgenic mice did not develop diabetes when infected with LCMV, suggesting that perforin-dependent cytotoxicity was crucial to cause diabetes by eliminating β cells (17). However, they did show insulitis, indicating that triggering islet inflammation required the perforin-independent pathway, which initially impaired β cells, exposed autoantigens to antigen-presenting cells, and launched an autoimmune cascade to diabetes. Our observation revealed that the Fas-dependent pathway might be precisely a complementary mechanism to initiate β cell destruction. NOD mice became completely free of insulitis by obtaining Fas-disrupting spontaneous mutation of lpr. Of course, there is a possibility that the lack of insulitis in NOD-lpr/lpr is due to the distorted T cell composition that contained unusual CD4–CD8– cells. To avoid this influence, we performed transfer experiments from diabetic NOD to sublethally irradiated young congenic mice.

Even in this protocol, insulitis and diabetes were completely prevented in NOD-lpr/lpr, whereas they were rapidly induced in the littermates not homozygous for lpr. This finding strongly suggests that autoimmune cascade against pancreatic β cells is blocked at an early stage in Fas-lacking NOD mice. Transferred autoreactive T cells might initially damage β cells through Fas–FasL system, and then substantially destroy fragile target cells by other mediators such as perforin and cytokines. Two groups have reported that β cells can express Fas when stimulated with IL-1 (26, 27). IL-1 is a cytokine secreted by macrophages, the participation of which has already been proved essential for the onset of diabetes as well as T cells (28).

During the process of backcrossing, we screened H-2g7 (Idd1) homozygotes at the N2 generation and lpr mutation at each generation. This implies that the prevention of insulitis and diabetes observed in NOD-lpr/lpr might be due to the absence of other Idd genes or the presence of unknown recessive genes linked to lpr mutation. However, microsatellite marker analysis revealed that other Idd loci significantly linked to insulitis and diabetes were replaced by the NOD alleles. In addition, either the incidence of diabetes in NOD-+/+ and NOD-+/lpr, or the protection of insulitis and diabetes in NOD-lpr/lpr did not change among the intercross with various recombinational positions from the Fas locus. This suggests that lpr mutation itself is responsible for the lack of disease in NOD-lpr/lpr.

To elaborate effective intervention therapies for IDDM, a better understanding of the pathogenesis is required. Given the fact that the Fas–FasL system is involved in the development of autoimmune diabetes, interference of this molecular mechanism would be a potent therapeutic strategy. Soluble form of Fas and anti-FasL Ab suppressed Fas-mediated cytotoxic activity (29, 30). Inhibitors of IL-1β–converting enzyme– or CPP32–like proteases blocked Fas-induced death signaling (31). If we devise a system to deliver one of these molecules at the site of inflammation, it might be a new beneficial treatment without systemic harmful effects for pre- and early stage of IDDM.

In conclusion, we have shown that autoimmune β cell destruction is prevented by introduction of Fas-disrupting lpr mutation into NOD mice. Considering that islet inflammation was nearly completely abrogated, Fas-based cytotoxic mechanism is assumed to be critical in an initial step of β cell autoimmunity. Since there have been many β cell–specific T cell clones and lines, the analysis of cytotoxic pathways and abilities to induce diabetes of these cells would provide further evidence concerning the Fas–FasL system in IDDM.


   Acknowledgments
 
We thank Ms. Katsumi Yamamori for excellent histological preparation.

This work was supported by Grants-in-aid by Ministry of Education, Culture and Sciences in Japan, Ministry of Health and Welfare in Japan, and The Japan Medical Association.

Submitted: 21 April 1997
Revised: 12 June 1997

This study was presented in part at the 57th ADA Meeting, Boston, MA, June 21–24, 1997.


   References
Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

1 Castano L & Eisenbarth GS. Type I diabetes: a chronic autoimmune disease of human, mouse and rat, Annu Rev Immunol, 1990, 8, 647–679.[Medline]

2 Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease, Endocr Rev, 1994, 15, 516–542.[Abstract/Free Full Text]

3 Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF & Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis, N Engl J Med, 1985, 313, 353–360.[Abstract]

4 Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M et al.. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients, J Clin Invest, 1993, 92, 2313–2322.[Medline]

5 Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernandez-Figueras MT, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D & Pujol-Borrell R. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile, J Immunol, 1994, 153, 1360–1377.[Abstract]

6 Kikutani H & Makino S. The murine autoimmune diabetes model: NOD and related strains, Adv Immunol, 1992, 51, 285–322.[Medline]

7 Koike T, Itoh Y, Ishii T, Ito I, Takabayashi K, Maruyama N, Tomioka H & Yoshida S. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice, Diabetes, 1987, 36, 539–541.[Abstract]

8 Shizuru JA, Taylor-Edwards S, Banks BA, Gregory AK & Fathman CG. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T helper lymphocytes, Science (Wash DC), 1988, 240, 659–662.[Abstract/Free Full Text]

9 Bendelac A, Carnaud C, Boitard C & Bach JF. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+T cells, J Exp Med, 1987, 166, 823–832.[Abstract/Free Full Text]

10 Miller BJ, Appel MC, O'Neil JJ & Wicker LS. Both the Lyt-2+ and L3T4+T cell subsets are required for the transfer of diabetes in nonobese diabetic mice, J Immunol, 1988, 140, 52–58.[Abstract]

11 Haskins K & McDuffie M. Acceleration of diabetes in young NOD mice with a CD4+islet-specific T cell clone, Science (Wash DC), 1990, 249, 1433–1436.[Abstract/Free Full Text]

12 Wong FS, Visintin I, Wen L, Flavell RA & Janeway CA Jr. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells, J Exp Med, 1996, 183, 67–76.[Abstract/Free Full Text]

13 Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H & Golstein P. Fas and perforin pathways as major mechanisms of T cell–mediated cytotoxicity, Science (Wash DC), 1994, 265, 528–530.[Abstract/Free Full Text]

14 Lowin B, Hahne M, Mattmann C & Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways, Nature (Lond), 1994, 370, 650–652.[Medline]

15 Kojima H, Shinohara N, Hanaoka S, Someya-Shirota Y, Takagaki Y, Ohno H, Saito T, Katayama T, Yagita H, Okumura K et al.. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes, Immunity, 1994, 1, 357–364.[Medline]

16 Young LH, Peterson LB, Wicker LS, Persechini PM & Young JD. In vivo expression of perforin by CD8+lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice, J Immunol, 1989, 143, 3994–3999.[Abstract]

17 Kagi D, Odermatt B, Ohashi PS, Zinkernagel RM & Hengartner H. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity, J Exp Med, 1996, 183, 2143–2152.[Abstract/Free Full Text]

18 Nagata S & Golstein P. The Fas death factor, Science (Wash DC), 1995, 267, 1449–1456.[Abstract/Free Full Text]

19 Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H et al.. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex, Science (Wash DC), 1986, 231, 733–735.[Abstract/Free Full Text]

20 Adachi M, Watanabe-Fukunaga R & Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lprmice, Proc Natl Acad Sci USA, 1993, 90, 1756–1760.[Abstract/Free Full Text]

21 Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA & Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis, Nature (Lond), 1992, 356, 314–317.[Medline]

22 Wicker LS, Miller BJ & Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from non-obese diabetic (NOD) mice, Diabetes, 1986, 35, 855–860.[Abstract]

23 Ghosh S, Palmer SM, Rodrigues NR, Cordell HJ, Hearne CM, Cornall RJ, Prins JB, McShane P, Lathrop GM, Peterson LB et al.. Polygenic control of autoimmune diabetes in nonobese diabetic mice, Nat Genet, 1993, 4, 404–409.[Medline]

24 Wicker LS, Todd JA, Prins JB, Podolin PL, Renjilian RJ & Peterson LB. Resistance alleles at two non– major histocompatibility complex–linked insulin-dependent diabetes loci on chromosome 3, Idd3, and Idd10, protect nonobese diabetic mice from diabetes, J Exp Med, 1994, 180, 1705–1713.[Abstract/Free Full Text]

25 Dietrich WF, Miller J, Steen R, Merchant MA, Damron-Boles D, Husain Z, Dredge R, Daly MJ, Ingalls KA, O'Conner TJ et al.. A comprehensive genetic map of the mouse genome, Nature (Lond), 1996, 380, 149–152.[Medline]

26 Stassi G, Todaro M, Richiusa P, Giordano M, Mattina A, Sbriglia MS, Lo A, Monte, Buscemi G, Galluzzo A & Giordano C. Expression of apoptosis-inducing CD95 (Fas/ Apo-1) on human β-cells sorted by flow-cytometry and cultured in vitro, Transplant Proc, 1995, 27, 3271–3275.[Medline]

27 Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C & Nonaka K. Mouse islet cell lysis mediated by interleukin-1–induced Fas, Diabetologia, 1996, 39, 1306–1312.[Medline]

28 Hutchings P, Rosen H, O'Reilly L, Simpson E, Gordon S & Cooke A. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages, Nature (Lond), 1990, 348, 639–642.[Medline]

29 Kondo T, Suda T, Fukuyama H, Adachi M & Nagata S. Essential roles of the Fas ligand in the development of hepatitis, Nat Med, 1997, 3, 409–413.[Medline]

30 Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S et al.. Fas ligand in human serum, Nat Med, 1996, 2, 317–322.[Medline]

31 Enari M, Talanian RV, Wong WW & Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis, Nature (Lond), 1996, 380, 723–726.[Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF, 228K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Itoh, N.
Right arrow Articles by Matsuzawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itoh, N.
Right arrow Articles by Matsuzawa, Y.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS